COMPANIES DATABASE

Company name Category Subcategory Company Type Headquarters (City) Headquarters (Country) Year Founded Total Funding, $M Last Round IPO/Stock
Abeona Therapeutics Drug Discovery Rare and orphan diseases Public Dallas USA 1989 38.43 $8.5M (Venture) in July, 2015 from 1 Investor (George Soros) Dec 18, 2014/NASDAQ:ABEO
AgeX Regenerative Medicine Stem Cells Private Alameda USA 2017 0.00 Unknown Unknown
AGTC Drug Discovery Various Public Florida USA 1999 78.05 $37.5M Mar 27, 2014 / NASDAQ:AGTC
Alkahest Geroscience Neuroscience Private San Francisco USA 2014 37.50 $37.5 M Unknown
Antoxis Geroscience Oxidative Stress Private Aberdeen UK 2005 2.00 Unknown Unknown
AstraZeneca Drug Discovery Various Public Cambridge UK 1999 0.00 Unknown May 21, 1993/LSE:AZN
Athersys Drug Discovery Various Private Delaware USA 1995 65.10 $23M (Post Ipo Equity) in Feb, 2017 (Investors Undisclosed) Unknown
Atlas Regeneration Software Development Bioinformatics Private Unknown Unknown 2014 0.00 Unknown Unknown
AxoGen Regenerative Medicine/Geroscience Neuroscience Public Florida USA 1995 69.92 $17.5M (Post Ipo Equity) in Aug, 2015 from 1 Investor (Essex Woodlands Health
Ventures)
NASDAQ:AXGN
Axonia Medical Regenerative Medicine/Geroscience Neuroscience Private Unknown Czech Republic Unknown 8.39 $2M Seed in June 2014: Biosciences Research and Commercialization Center (BRCC),
SWMF Life Science Fund, Research Emeritus, University of Michigan
Unknown
BGI Software Development Bioinformatics Private Beijing People's Republic of China 1999 875.86 $653.86M (Series B) in January 2015 from 1 Investor (Magic Stone Alternative) Unknown
BIOAGE Labs Geroscience - Private Berkeley USA Unknown 0.00 Unknown Unknown
BioLife Solutions Regenerative Medicine Biopreservation Public Delaware USA 1987 15.40 Unknown Unknown
BioMarin Drug Discovery Rare and orphan diseases Public San Rafael USA 1997 0.00 Unknown Jul 23, 1999/ NASDAQ:BMRN
BioMarker Pharmaceuticals Geroscience Consumer Care Private California USA Unknown 0.00 Unknown Unknown
BioTime Regenerative Medicine Stem cells Public California USA 1990 76.38 $10.55M (Post Ipo Equity) in Sep, 2016 May 5, 1992 / NYSEMKT:BTX
Bluebird Bio Gene Therapy Bioinformatics Public Unknown USA 1992 409.00 $250M Jun 19, 2013 / NASDAQ:BLUE
Calico Geroscience Neuroscience Private California USA 2013 1500.00 Unknown Unknown
Cell Habitats Regenerative Medicine/Geroscience Stem cells Private Woodridge USA 2012 6.40 $6.4M (Grant) in 2005 from 1 Investor (National Heart, Lung and Blood Institute) Unknown
CellAge Geroscience Cellular Senescence Private Glasgow UK 2016 0.00 $34K (Crowdfunding) in February 2017 Unknown
Celularity Regenerative Medicine Stem Cells Private USA USA Unknown 0.00 Unknown Unknown
Centagen Regenerative Medicine Stem Cells Private Boulder USA 2009 0.00 Unknown Unknown
Centrillion Technologies Diagnostics Genomic Testing Private Palo Alto USA 2016 24.30 $9M Series B in April 2013 Unknown
Chipscreen Drug Discovery Oncology Private People's Republic of China China Unknown 0.00 $7.7M (Venture) in April 2015 from 2 Investors (LYZZ Capital, Vertex Ventures) Unknown
Chronos Therapeutics Geroscience Neuroscience Private Oxford UK Unknown 0.00 $12.12M (investment type undisclosed) in December 2013 from 4 Investors (Odey
Asset Management, Odey Swan, Testudo Funds, University of Oxford)
Unknown
CohBar Drug Discovery Various Private Menlo Park USA 2007 0.45 $450K in Feb, 2014 (Investors Undisclosed) Unknown
Color Genomics Diagnostics Genomic Testing Private California USA 2013 98.55 $45M Series B in September 2016: General Catalyst (Lead investor), Emerson Collective,
Khosla Ventures
Unknown
Cyfuse Biomedical Regenerative Medicine Tissue engineering Private Japan Japan Unknown 12.00 $12M (Venture) in Mar, 2015 from 2 Investors (Cyberdyne, Shibuya Kogyo) Unknown
Cytori Regenerative Medicine/Geroscience Stem cells Private San Diego USA 1996 71.85 $17.1M (Post Ipo Equity) in Jun, 2016 (Investors Undisclosed) Unknown
Draxis Health Geroscience Neuroscience Private Ontario Canada 1987 0.00 Unknown Unknown
Editas Medicine Drug Discovery Various Private Unknown USA 2013 71.85 $120M Unknown
Elysium Health Geroscience Consumer Care Private California USA 2015 20.00 $20M (Series B) in Dec, 2016 from 2 investors (General Catalyst, Robert Nelson) Unknown
Emulate Regenerative Medicine Tissue engineering Private Massachusetts USA 2013 57.00 $12M (Series A) in July 2014: NanoDimension, Cedars Sinai Medical Center Unknown
Epitracker Geroscience Epigenetics Private Unknown Unknown Unknown 0.00 Unknown Unknown
Eve Biomedical Diagnostics Consumer Care Private California USA 2012 7.67 $6M Unknown
Everist Health Geroscience Cardiovascular Disieases Private Ann Arbor USA 2001 12.54 $9.48M (Venture) in February 2012 (investors not disclosed) Unknown
Everon Biosciences Geroscience Cellular Senescence Private Buffalo USA Unknown 8.88 $5M Unknown
Evox Therapeutics Drug Discovery Various Private Oxford UK 2016 14.43 $14.43M (Seed) in May 2016: Oxford Sciences Innovation Unknown
Fibrocell Geroscience Various Private Pensylvania USA 1992 104.46 $17.63M Unknown
Fronteo Software Development Machine Learning Private Japan Japan 2003 0.00 Unknown Unknown
GC-Rise Pharma Geroscience Various Private Unknown China 2008 19.74 $15M (Series B) in Sep, 2014: OrbiMed Unknown
Genescient Corp Diagnostics/Geroscience - Private California USA 2006 0.00 $500k (Angel Funding) in December, 2009 (investor undisclosed) Unknown
Genos Diagnostics Genomic Testing Private California USA 2016 0.00 Unknown Unknown
GenSight Biologics Regenerative Medicine Ocular diseases Public France France Unknown 77.67 $36M (Series B) from Abingworth',Fidelity Management and Research Company, HealthCap, Index Ventures,
Jennison Associates, Novartis Venture Fund, Perceptive Advisors, Sphera Funds Management, and
Varsant Ventures
Jul 13, 2016 / NASDAQ:GNST
Genzyme Corporation Drug Discovery Rare and orphan diseases Private Massachusetts USA 1981 0.00 Unknown Unknown
Geron Geroscience Telomere therapy Private Unknown Unknown Unknown 96.70 $96.7M (Post IPO) in Feb, 2014 Unknown
Harbour Biomed Drug Discovery Oncology Private Unknown China 2016 50.00 $50M (Series A) in Dec, 2016 (Advantech Capital, Legend Capital) Unknown
Helix Diagnostics Genomic Testing Private Unknown USA 2015 100.00 $100M Unknown
Hua Medicine Geroscience Neuroscience Private Unknown China 2010 125.00 $50M (Series C) in Apr, 2016 from: Harvest Global Investments Unknown
Human Longevity Inc. Geroscience Various Private San Diego USA 2013 300.00 $220M (Series B) in Apr, 2016 from: Illumina, Amino Capital, Celgene, Draper Fisher
Jurvetson, GE Ventures, StartUp Health
Unknown
Ichor Therapeutics Regenerative Medicine/Geroscience Ocular diseases Private Lafayette USA 2013 2.49 $600k in July, 2016 (Investors Undisclosed) Unknown
Inception Sciences Drug Discovery Various Private San Diego USA 2011 20.00 $5M (Venture) in Jun, 2014 from Undisclosed investor Unknown
Inform Genomics Gene Therapy Testing Private Boston USA Unknown 3.93 $2.6M Unknown
Insilico Medicine Geroscience Machine Learninig Private Baltimore USA 2013 10.00 $10M (Venture) in Feb, 2017 from Undisclosed investor Unknown
Interprotein Drug Discovery - Private Unknown Japan 2001 2.95 Unknown Unknown
Juventas Therapeutics Regenerative Medicine Various Private Minnesota USA Unknown 41.00 $13.5M (Series B) in May, 2015 from; Green Cross, POSCO Venture capital Unknown
Kailos Genetics Diagnostics Genomic Testing Private Alabama USA 2011 1.90 Unknown Unknown
Leadhexa Biotechnologies Geroscience Oxidative Stress Private Delaware USA Unknown 0.00 Unknown Unknown
LifeGen Geroscience Epigenetics Private Unknown USA 2000 0.00 $11,7M (Aquisition) in December, 2011 from Nu Skin Enterprices Unknown
Longevity Biotech Drug Discovery Various Private Philadelphia USA 2010 0.52 $350K (Grant) in Apr, 2012 from Thiel Foundation Unknown
LPixel Software Development Machine Learning Private Unknown Japan 2014 7.00 $7M Unknown
Lysogene Geroscience Neuroscience Private Unknown France 2009 22.00 $22M Unknown
MacuCLEAR Drug Discovery Ocular diseases Private Texas USA 2006 1.00 $1M (Venture) in Jan, 2012 Unknown
Mesoblast Regenerative Medicine/Geroscience Stem Cells Private Australia Australia 2004 6.20 $6.2M (Venture) in May, 2016 from Australian Government for Research and
Development
Unknown
Metabomed Drug Discovery Oncology Private Israel Israel 2014 18.00 $18M (Series A) in Apr, 2016 from; Arkin Holdings, Boehringer Ingelheim Venture Fund,
Merck Ventures, Pfizer, Pontifax Funds
Unknown
MitoBridge Geroscience Oxidative Stress Private Unknown USA Unknown 45.00 Unknown Unknown
Mitotech Geroscience Various Private Unknown Luxembourg Unknown 0.00 Unknown Unknown
Navitor Gene Therapy Ocular diseases Private North Mankato USA Unknown 56.50 $33M (Series B) in Dec, 2015 from 7 investors (Atlas Venture, Johnson & Johnson Innovation ,
Polaris Partners, Remeditex Ventures, Sanofi-Genzyme, BioVentures and SR One)
Unknown
NightstaRx Gene Therapy Various Private London UK 2013 54.63 $35M Unknown
NovaDip Biosciences Regenerative Medicine Tissue engineering Private Unknown Belgium 2013 31.46 $31.46M Series A in September 2015: Intergrale Advisors, New Science Ventures,
Ninelinvest, S.R.I.W., Vives Fund
Unknown
NovaHep Regenerative Medicine Tissue engineering Private Unknown Sweden 2005 0.00 Unknown Unknown
NOX Technologies Diagnostics Oncology Private Unknown USA 2003 0.63 $125K Seed, in July 2014
NuSirt Geroscience Metabolic disorders Private Nashwille USA 2007 13.98 $6M (Series C) in May, 2015 from; Hatteras venture partners, Mountain Group Capital,
TriStar Technology Ventures, Tennessee Community Ventures
Unknown
Oisin Biotechnologies Geroscience Cellular Senescence Private Unknown USA Unknown 0.00 Unknown Unknown
Orig3n Diagnostics - Private Massachusetts USA 2014 15.60 $12.5M Series A in December 2015: Hatteras Ventures, Syno Capital, DEFTA Partners,
Harris & Harris Group, KTB-KORUS Fund, LabCorp, Mountains Group Capital
Unknown
Orthomolecular Research Regenerative Medicine Consumer Care Private Canada Canada 1991 0.00 Unknown Unknown
Osiris Green Gene Therapy Rare and orphan diseases Private Unknown USA 2016 0.00 Unknown Unknown
Osiris Therapeutics Regenerative Medicine Various Private Columbia USA 1992 15.00 Unknown Unknown
Oxstem Regenerative Medicine/Geroscience Stem Cells Private Oxford UK 2013 24.38 Unknown Unknown
Pentraxin Drug Discovery Immunotherapy Private London UK 2011 0.00 Unknown Unknown
PHIGENIX Diagnostics Oncology Private Atlanta USA Unknown 4.56 $842.4K 2 Rounds (Undisclosed Investors) Unknown
Pluristem Drug Discovery Various Private Unknown Israel 2001 24.67 $3.3M Unknown
Population Bio Diagnostics Genomic Testing Private Unknown USA 2006 0.00 $5.36M Series A in August 2011 from 1 Investor (Undisclosed) Unknown
Prana Biotechnology Geroscience Neuroscience Public Florida USA 1997 0.00 Unknown 2002 / NASDAQ:PRAN
Progenitor Therapeutics Regenerative Medicine Tissue engineering Private Unknown UK 2010 6.04 $6.04M Unknown
Proteostasis Therapeutics Drug Discovery Various Public Massachusetts USA 2006 160.64 $50M Feb 11, 2016 NASDAQ:PTI
PureTech Health Geroscience Oxidative Stress Private Massachusetts USA 2015 0.00 Unknown Unknown
Quark Pharmaceuticals Drug Discovery Various Private Unknown Israel 2003 61.40 $10M (Venture) in Jun, 2010 (investors undisclosed) Unknown
Quincy Bioscience Geroscience Neuroscience Private Wisconsin USA 2004 8.42 $240K Unknown
Rapamycin Holdinds Geroscience Oncology Private Texas USA 2012 3.93 $3.93M Unknown
Regenxbio Gene Therapy Ocular diseases Public Rockwell USA 2008 205.00 $60M Sep 8, 2015
ReThink Pharmaceuticals Drug Discovery Various Private Unknown Israel Unknown 0.10 $10K Unknown
Retrotope Geroscience Oxidative Stress Private Los Altos USA 2006 14.53 $14.53M (Venture) in March, 2016 (Timur Artemiev) Unknown
Revance Therapeutics Drug Discovery Dermatology Public California USA 2014 333.98 $96M NAS: RVNC
RondinX Drug Discovery Various Private Unknown Israel 2015 2.50 $2.5M Unknown
Samumed Gene Therapy Oncology Private San Diego USA Unknown 50.00 $50M Unknown
Sangamo Biosciences Gene Therapy Rare and orphan diseases Public California USA 1995 74.20 $74.2M Apr 14, 2000
Sangui Biotech International Regenerative Medicine/Geroscience Cardiovascular Disieases Public Unknown Germany 1995 0.00 Unknown PINX: SGBI
Semma Therapeutics Regenerative Medicine/Geroscience Stem Cells Private Unknown USA 2015 99.00 $49M Unknown
Sierra Sciences Geroscience Telomere therapy Private Reno USA 1997 0.00 Unknown Unknown
Signum Geroscience Various Private Princeton USA 2002 5.60 $1.6M (Grant) in November, 2013 Unknown
Silene Biotech Regenerative Medicine Biopreservation Private Seattle USA Unknown 0.26 $200K Unknown
SIWA Therapeutics Geroscience Cellular Senescence Private Unknown Unknown Unknown 0.40 Unknown Unknown
Spark Therapeutics Gene Therapy Various Public Philadelphia USA 2013 268.00 $161M Jan 30, 2015 / NASDAQ:ONCE
SQZ Biotech Drug Discovery Drug Delivery Private Unknown USA 2013 4.56 $4M Series B in December 2016: Quark ventur Unknown
TauRx Therapeutics Geroscience Neuroscience Private Unknown Singapore 2002 277.33 $135M Unknown
UniQure Regenerative Medicine Various Public Unknown Netherlands 2014 78.00 $20M Feb 6, 2014
Unity Biotechnology Geroscience Senolytic drugs Private Brisbane USA 2009 118.79 $116M Unknown
Universal Cells Regenerative Medicine Stem Cells Private Unknown USA 2013 0.30 $300K Seed, in July 2014 (Investors Undisclosed) Unknown
Vault Regenerative Medicine Biopreservation Private Unknown USA Unknown 0.20 $200K Unknown
Vericel Corporation Regenerative Medicine Tissue engineering Public Unknown USA 1989 61.00 $40M Feb 4, 1997 / NASDAQ:VCEL
Veritas Genetics Diagnostics Genomic Testing Private Unknown USA 2014 4.56 $30M Unknown
Videregen Regenerative Medicine Tissue engineering Private London UK 2011 4.98 $4.98M Unknown
Visgeneer Geroscience Dermatology Public Unknown Taiwan Unknown 0.00 Unknown ROCO: 4197
Vitruvian Networks Drug Discovery Drug Delivery Private San Francisco USA Unknown 12.81 $12.81M in 1 Round from one ivestor on November 30, 2016 Unknown
Voyager Therapeutics Geroscience Neuroscience Private Unknown USA 2013 108.39 $70.5M Unknown